about
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaIndian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.Early Experience of Sofosbuvir based Combination Therapy in "Real-Life" Cohort with Chronic Hepatitis-C Infection.Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C.Hepatitis C in Pakistan: a review of available data.Effect of end-stage renal disease on oral health in patients undergoing renal dialysis: A cross-sectional study.Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern IndiaSeroprevalence and Risk Factors for Hepatitis C Virus Infection among General Population in Central Region of Yemen.Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India.Utility of FNAC in Conjunction with Cell Block for Diagnosing Space-Occupying Lesion (SOL) of Liver with Emphasis on Differentiating Hepatocellular Carcinoma from Metastatic SOL: Analysis of 61 CasesTransfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of DelhiProfile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in uttarakhand.Cancer incidence among Asian American populations in the United States, 2009-2011.Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays.Transfusion transmitted infections in thalassaemics: need for reappraisal of blood screening strategy in India.Hepatitis B and C in Children.Genotype 3 and higher low-density lipoprotein levels are predictors of good response to treatment of recurrent hepatitis C following living donor liver transplantation.Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India.Viral Hepatitis Surveillance--India, 2011-2013.Clinical Profile and Response to Treatment with Pegylated Interferon α 2b and Ribavirin in Chronic Hepatitis C-A Reappraisal from a Tertiary Care Center in Northern India.Prevalence of hepatitis B and C in puducherry.Population-based hepatitis C survey in a rural block.Diversity of genotype and mode of spread of Hepatitis C virus in Northern India.Protective effect of Amaranthus spinosus against D-galactosamine/lipopolysaccharide-induced hepatic failure.Viral hepatitis eradication in India by 2080--gaps, challenges & targets.Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey.Hepatitis B, hepatitis C and HIV co-infection at an antiretroviral centre in Delhi.Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five-year study.Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment.Hepatitis C worldwide and in Brazil: silent epidemic--data on disease including incidence, transmission, prevention, and treatment.Universal screening: To do or not to do.Dynamics of Hepatitis C Virus Infection: Mathematical Modeling and Parameter EstimationComparative Antiviral Efficacy of Generic Sofosbuvir versus Brand Name Sofosbuvir with Ribavirin for the Treatment of Hepatitis C
P2860
Q27010612-ACDFC846-0EA7-4F62-81BC-BF333607B542Q30355190-9143BF3C-5A9D-439C-A621-4005BE332D24Q33666545-AECA0ADF-00F3-4D90-9A0B-9D0B9C5D621FQ33783604-281B7762-F5B5-478B-A608-E71B53E35BA8Q33948241-84CC3A4A-0194-4B64-AC8D-215A8DE89A6EQ34151617-DEFF2DA8-DC0E-40E1-AB53-D015B822F446Q34405507-3D983881-6CD9-4828-B2BA-63E1CEF8E514Q34558519-9B6DC867-B290-4BAB-A97C-64C47F1E383AQ35818327-2CDF5D61-17AB-4AAD-8293-3C055FB6AE47Q36347429-1832B3CA-E5EF-4446-A1B4-6B1B47803609Q36505749-AB48377F-A12F-4E52-B58B-3DDA388DA537Q36662773-9A160BAE-068A-424F-B62E-E5F505C1B5A1Q36884475-463B90BA-3317-4A43-AD1A-FF8F1B9F8F01Q37133674-A6CF18D4-DA2C-4140-BBC4-6F4238B6E46AQ37613141-501F012A-ACC0-4901-9CDB-C12F98D4A89FQ37616452-7DF51665-3C3D-4C11-BB8E-0FFF6E8A6D0FQ37618606-525EFB4B-075C-49F9-B1E3-8398C91BA701Q38194183-F01B4A7C-DDE0-4AB8-BDD2-AE9CABF9FA34Q38812250-199DF3B7-5131-4583-BDC6-BDF41779D930Q38961331-7A6C7082-6E1C-47DA-9237-B0E1ABB9ACB5Q40668424-2F5504DF-CEC4-4203-B630-048F7D7EDE7AQ40704618-59B31F22-73C1-4F08-BE7F-7A0715825FCCQ41258033-7571C7A8-391F-4EDB-B615-A938687570A6Q41258068-E252EE79-262C-455E-9608-15ABA40F32F1Q41666600-CEC181E3-9CDA-46FE-87AB-579E2C210FCAQ42794896-F54192D9-2A0F-4F75-9A73-226FB05BB86DQ42879856-EE96CAC5-4E14-403F-ADC3-113AAB826D97Q42923174-B3B939BC-5450-4B34-B280-A0650775E094Q42985162-9C7B038A-8859-45E2-B8D8-6CC752550038Q43036885-01C123FF-E3B4-475D-A9DA-75E308316E88Q45374192-9DD916AD-BD2E-4828-8B0F-984D53B912CDQ50553459-103E1FB4-A4FE-458A-9CF6-DDCC97FB2E38Q51837887-9A20FA2A-D8CB-4FB0-805F-649E30177ABAQ55009826-F8C9E7EB-BFE4-445F-97B8-A59FC8E2C0DEQ56786953-99174EFE-238E-4281-A13B-74FBAAF0355EQ58593930-36D6A8E3-D8A2-44BB-B679-1B7B75FEDAF3
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Hepatitis C in India.
@en
Hepatitis C in India.
@nl
type
label
Hepatitis C in India.
@en
Hepatitis C in India.
@nl
prefLabel
Hepatitis C in India.
@en
Hepatitis C in India.
@nl
P1476
Hepatitis C in India.
@en
P2093
Ashis Mukhopadhyaya
P2860
P2888
P304
P356
10.1007/S12038-008-0065-0
P577
2008-11-01T00:00:00Z